Beruflich Dokumente
Kultur Dokumente
Alit Aryani
Psychiatric Departement
Medicine Faculty Udayana University
Introduction
Substance abuse problem cause significant
disabilities
Illicit substance abuse affects multiple area of
functioning and comorbid diagnosis occurs in
about 60-70% of patients with substance
related disorder
Substance abuse can mimic psychiatric
ilnesses include psychotic, anxiety, and
depression
TYPE. I NARCOTIC
For knowledge not for therapy
High potention for addiction
Example -HEROIN
-COCCAIN
-CANABIS
TYPE II NARCOTIC
For therapy and knowledge
High Potention for addiction
Example : -MORFIN
-PETHIDIN
TYPE III NARCOTIC
For therapy and knowledge
Low potention for addiction
Example : CODEIN
TYPE I PSYCHOTROPIC
For knowledge not for therapy
Hallucination effect
1. organo-biologik
genetic factor
Neurotransmitter defisit
2. Psychologic factor
oral phase fixation
antisocial personality
3. Sosio cultural/environment
Stress, unhappy family
black market
weakness of law regulation
ETIOLOGIC
INDIVIDUAL ENVIRONMENT
SUBSTANCE
INDIVIDUAL FACTOR
EXPERIMENTAL USE
LOW SELF ESTEEM
LOW SELF CONFIDENCE
ANTISOCIAL PERSONALITY
LOOKING FOR SELF IDENTITY
HAVING STRESOR/ PROBLEM
IMMATURE DEFENCE MECHANISM
RELIGY
BROKEN HOME
GRADE OF DRUG USER
I. EXPERIMENTAL USE
II. SOCIAL USE/HAVING FUN/RECREATIONAL
USE
III. SITUATIONAL USE
IV. ABUSE
V. DEPENDENCE/TOLERANCE-WITHDRAWL
Evaluation
Often difficult to detect and evaluate
They are often manipulative, denial, and fear
the consequences of acknowledging the
problem It is necessary to obtain
information from other sources
Substance abuse is frequently associated with
personality disorders (antisocial, borderline,
narcissistic)
1.Anamnesis : History ; continuous or episodic
2.Toxicology (urine, hair, blood test, saliva)
3. Physical examination
Subcutaneus or intravenous abusers : AIDS, scars,
abcess, infection, thrombophlebitis
Snorter of coccaine, heroin, other drugs :
deviated of nasal septum, nasal bleeding, rhinitis
Smokers of marijuana or other drugs, inhalant
abusers : bronchitis, asthma, chronic respiratory
condition
4. Psychometry : ASSIST, ASI
Coccain
Effect : Stimulans
withdrawal :
1. fatique
2. Nigthmare
3. Insomnia
4. Retardation psychomotor
Therapy
Antidepresant
- Bupropion
- MAOI
- SSRI
- Fluoxetin
- Sertralin
INTOXICATION
1. Tachycardia / brodycardia
2. pupillary dilation
3. Blood pressure /
4. Nausea and vomiting
5. Agitation
6. Chest pain, aritmia
7. Confusion , seizure
Therapy :
- Lithium
- Dilantin
ALCOHOL
production of somnolence and decreased neuronal activity but
not powerful in attenuating pain
Craving
Activation of limbic system, the orbitofrontal and insular cortex,
as well as in the cerebellum
Blackout
Memory impairment for the period when a person was drinking
heavily but remained awake
Sleep impairment
Suppresses REM, inhibits stage 4 sleep, sleep fragmentation,
intense and disturbing dreams
Cerebellar degeneration
Unsteadiness of gait, mild nystagmus, problems with standing
steadiness
Peripheral neuropathy
Numbness of extremities, tingling and paresthesias
Gastrointestinal problems
Acute inflamation of esophagus/stomach, esophageal vein
bleeding, fatty liver, hepatitis, cirrohis, pancreatitis
Cancer
Tumors of head neck esophagus stomach, liver, colon, lungs,
breast
Fetal Acohol Effects
Fetal death, spontaneous abortion, mental retardation, small
head, low birth weight, facial abnormalities, atrial septal defect,
syndactyly
Other problems
Testicular atrophy, bone fractures, cataracts, dental difficulties,
muscle wasting, increase risk of accident
1. Intervention
Principles of motivational interviewing to break through denial
and help patient recognize the adverse conseqences for drinking
alocohol.
4. Topiramate-anticonvulsant
5. Ondansentron-serotonin 3 receptor antagonist
6. SSSRI, GABA-B receptor agonist Baclofen
7. antipsychotic
OPIOID
WITHDRAWAL INTOXICATION
Opioid Pain Drowsiness coma
Nausea, Vomiting Slurred speech
diarrhea Impairment attention
Insomnia or memory
Anxiety Pupillary constriction
Pupillary dilation Blood pressure
Fever Respiration rate
Respiration rate Heart rate
Heart rate Behavioral
Dysphoric mood psychological change
restlessness
Differential Diagnosis
Opioid-induced
Opioid Induced Opioid Induced
Psycotic
Mood Disorder Sleep Disorder
Disorder
Treatment (1)
Self-
help
groups.
Individualiz Methadone
ed drug maintenance
counseling. treatment
Supportive- Opioid
expressive
psychothera
antagonist
py . treatment
Opioid
Outpatient
agonist-
drug-free
treatment. antagonist
treatment.
AMPHETAMINE (OR AMPHETAMINE-LIKE)
In addition to amphetamine itself, some members of this
class include:
- methamphetamine (METH)
- methcathinone, phentermine,
- methylenedioxyamphetamine (MDA)
- 3,4-methylenedioxymethamphetamine (MDMA)
- methylenedioxyethylamphetamine (MDEA)
Have classic psychostimulant properties
Amphetamine-like, example:
- methylphenidate
- caffein
DEFINITION
The individual must have a history of at least 3 of 7:
Tolerance
Withdrawal
Greater use of drug than intended
Inability to cut back on use
A great deal of time using drug
A reduction in social, occupational, or recreational
activities
Continued use despite being aware that use is
associated with problem
PHARMACOLOGY
The drugs produced acute psychomotor
stimulant effect
The pharmacokinetics of METH are dependent
on route of administration and dose.
Regardless of the route of administration, the
reinforcing effects of METH:
Euphoria
Power and confidence
Decreased need for sleep
Increased energy and concentration.
DIAGNOSIS AND CLINICAL FEATURES
AMPHETAMINE INTOXICATION
Diagnostic criteria:
A. Recent use of amphetamine or a related substance
B. Clinically significant maladaptive behavioral or psychological
changes that developed during, or shortly after use of
amphetamine or a related substance
C. 2 (or more) of the following, developed during, or shortly after
use of amphetamine or a related substance
1) Tachycardia or bradycardia
2) Pupillary dilation
3) Elevated or lowered blood pressure
4) Perspiration or chills
5) Nausea or vomiting
6) Evidence of weight loss
DIAGNOSIS AND CLINICAL FEATURES
AMPHETAMINE WITHDRAWAL
Diagnostic criteria:
A. Cessation of (or reduction) amphetamine (or related substance) use that
has been heavy and prolong
B. Dysphoric mood and two (or more) of the following, developing within a
few hours to several days after criteria A.
1) Fatigue
2) Vivid, unpleasant dreams
3) Insomnia or hypersomnia
4) Increased appetite
5) Psychomotor retardation or agitation
C. The symptom of criteria B cause significant distressnor impairment in
social, occupational, or other important areas of function
D. The symptoms are not due to a general medical condition and are not
better accounted for by another mental disorder.
DIAGNOSIS AND CLINICAL FEATURES
WITHDRAWAL INTOXICATION
Amphetamin fatigue Tachycardia/Bradycardia
(stimulan) Depresion Pupilary dilation
Hipersomnia Elevated blood pressure
Appetite Sweating
Nightmare Nausea, vomiting
Inability in Weight loss
concentration Depressed breath
Chest pain
TREATMENT
Psychological and behavioral treatment
approaches are the primary modality
Pharmacotherapy:
Bupropion, in combination with behavioral group
therapy
Antidepresan (withdrawal)
Mood stabilizer (manic)
Modafinil
Gamma-vinyl GABA
BENZODIAZEPIN
INTOXICATION
Benzodiazepine intoxication can be associated
with behavioral disinhibition, potentially
resulting in hostile or aggressive behavioral.
Combine with alcohol intoxication.
Benzodiazepine intoxication is associated with
less respiratory depression than barbiturate
intoxication.
WITHDRAWAL SYNDROME
The discontinuance syndrome may also be
divided into symptoms of :
Rebound
Recurrent
Withdrawal
Rebound Symptoms : those for which the
benzodiazepine was originally prescribed that
return in a more severe form than they had
before treatment.
Recurrent Symptoms : return of the original
symptoms at or below their original intensity.
WITHDRAWAL SYNDROME
Disturbances of mood and cognition
Anxiety, apprehension, dysphoria, pessimism,
irritability, obsessive rumination, and paranoid
ideation.
Disturbances of sleep
Insomnia, altered sleep-wake cycle, daytime
drowsiness
WITHDRAWAL SYNDROME
Physical sign and symptoms
Tachycardia, elevated blood pressure,
hyperreflexia, muscle tension, agitation,
tremor, myoclonus, muscle and joint pain,
nausea, coryza, diaphoresis, ataxia, tinnitus,
and grand mal seizure.
Perception disturbances
Hyperarcusis, depersonalisasi, blurred vision,
illusions, halusinasi.
RISK FACTOR
Dosage of benzodiazepine
Duration of benzodiazepine treatment
Rate of drug taper
Psychopathology (score MMPI-2 higher, high
prewithdrawal level of anxiety and depression,
lower educational level, and passive
dependent personality disorder).
sYMPTOMS
INTOXICATION WITHDRAWAL
Alcohol Maladaptive behavior and Autonomic hyperactivity
psychological change Insomnia
Slurred speech Increased hand tremor
Incoordination Nausea and vomiting
Unsteady gait Transient hallucination
Nystagmus Psychomotor agitation
Impairment memory or Anxiety
attention Grandmal seizure
Stupor or Coma Delirium Tremens (DTs)
INTOXICATION WITHDRAWAL
Canabis : euphoria anxiety,
Marijuana perceptual alteration Insomnia
Hasish intensification of Irritable
Ganja ordinary experiences apettite disturbance
such as eating, depression.-
watching films,
listening to music,
and engaging in sex.
Withdrawal :
Nicotine
Withdrawal :
1. dysphoric
2. Insomnia
3. angry
4. anxiety
5. Concentration difficulties
6. Agitation
7. Palpitation
8. Increase Appetite
Therapy
Nicotine replacement therapies
- Nicotine gum (nicorette)
- Nicotine patches (nicoderm)
- Nicotine nasal spray (nicotrol)
Non nicotine bupropion (zyban)
Clonidine
Psychoterapi
Hypnoterapi
Caffein
Effect Psychostimulans, diuretic
blood pressure
Withdrawal :
1. Fatique
2. Anxiety
3. Nausea and vomiting
Intoxication
1. Anxiety
2. Insomnia
3. diuresis
4. Muscle twitching
5. Tachycardia
6. Agitation
7. Rambling flow of thought and speech
Halusinogen
Intoxication
1. halusination, ilusi, depersonalisation, derealisation
2. Two or more symptoms :
- Pupillary dilation
- Tachycardia
- sweating
- Palpitation
- Blurred vision
- Tremor
- Incoordination
Therapy
Benzodiazepin clonazepam
Anti convulsant : valproic acid, carbamazepine
COMORBIDITIES
SCHIZOPHRENIA
MANIC
DEPRESSION
BIPOLAR DISORDER
MENTAL RETARDATION
CONDUCT DISORDER
PERSONALITY DISORDER
THANK YOU